effect gliclazid treatment insulin releas sensit endogen insulin niddm role initi continu subcutan insulin infusion-induc normoglycemia obes new-onset non-insulin-depend diabet niddm patient group continu subcutan insulin infus csii normoglycemia day blood glucos mmol/l mean daili blood glucos mmol/l end csii period excel glycem control insulin day hour endogen insulin product urinari c-peptid hour gliclazid group csii obes niddm patient group habitu hyperglycem state gliclazid group group excel metabol control appear small first-phas insulin respons intraven glucos signific increas mean-daily-insulin mean-daily-blood-glucos ratio urinari c-peptide-to-glucos ratio gliclazid effect pronounc group No signific effect efficaci endogen insulin slope disappear blood glucos insulin level month gliclazid treatment excel glycem control patient unchang stimul gliclazid first-phas insulin respons mean insulin-to-glucos urinari c-peptide-to-glucos ratio chang ratio glucos dispos endogen insulin physiolog insulin replac normoglycemia niddm insulin resist clinic signific gliclazid beta-cell-stimul action unchang month therapeut effect gliclazid niddm result beta-cytotroph action initi normoglycemia csii last effect gliclazid action 